Please login to the form below

Not currently logged in
Email:
Password:

Pneumococcal vaccine

This page shows the latest Pneumococcal vaccine news and features for those working in and with pharma, biotech and healthcare.

Solid Q1 results lift Pfizer as it waits for pipeline boost

Solid Q1 results lift Pfizer as it waits for pipeline boost

Pfizer’s Prevnar pneumococcal vaccine franchise grew 8% to $1.49bn, around $100m ahead of expectations, although analysts expressed concerns that Pfizer was at risk of falling behind in the race

Latest news

  • Pfizer’s Prevnar-13 successor takes aim at Merck rival Pfizer’s Prevnar-13 successor takes aim at Merck rival

    Rivals look to broaden coverage across strains. Pfizer just got a leg-up in its race with Merck &Co to bring a new-generation pneumococcal vaccine to the US market after ... is in pursuit of PCV-15 (also known as V114), a 15-valent candidate that Merck

  • Takeda's once-weekly DPP-4 inhibitor cleared in first market Takeda's once-weekly DPP-4 inhibitor cleared in first market

    The company also won Japanese approval for acne therapy Duac Combination Gel (clindamycin and benzoyl peroxide) and pneumococcal conjugate paediatric vaccine Synflorix. -

  • Pfizer's Prevenar 13 price cut slammed by MSF Pfizer's Prevenar 13 price cut slammed by MSF

    Pfizer has reduced the price of its pneumococcal vaccine Prevenar 13 for an immunisation programme targeting low-income countries, but has been criticised for not going far enough. ... However, medical charity Medecins Sans Frontieres (MSF) said the

  • CHMP thumbs up for Novo's obesity drug Saxenda CHMP thumbs up for Novo's obesity drug Saxenda

    Prevenar 13 also backed. Meanwhile, the CHMP has also issued a positive opinion for an application by Pfizer to extend the indications for its pneumococcal vaccine Prevenar 13 to include the ... prevention of pneumonia caused by the 13 pneumococcal

  • Call for GSK and Pfizer to reduce vaccine price Call for GSK and Pfizer to reduce vaccine price

    MSF campaigns to lower cost of pneumococcal shot to $5 per child in developing countries. ... with the Reach Every Child conference that will bring leading vaccine donors together in Berlin next week.

More from news
Approximately 1 fully matching, plus 34 partially matching documents found.

Latest Intelligence

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    26.6. ‡SK Chemicals/ Sanofi Pasteur. Collaboration. Pneumococcal conjugate vaccine (PCV). 23.

  • A tailored approach to the BRIC markets A tailored approach to the BRIC markets

    In 2009, GSK signed a 1.5bn deal with the Brazilian government to provide Syflorix, its vaccine for paediatric pneumococcal disease, at around a third of the price it charged in ... Europe. The deal guaranteed GSK a set price and set volumes for the

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics